A Comprehensive Analysis of Hungarian MODY Patients—Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases

MODY2 is caused by heterozygous inactivating mutations in the glucokinase (GCK) gene that result in persistent, stable and mild fasting hyperglycaemia (5.6–8.0 mmol/L, glycosylated haemoglobin range of 5.6–7.3%). Patients with GCK mutations usually do not require any drug treatment, except during pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaál, Zsolt, Szűcs, Zsuzsanna, Kántor, Irén, Luczay, Andrea, Tóth-Heyn, Péter, Benn, Orsolya, Felszeghy, Enikő, Karádi, Zsuzsanna, Madar, László, Balogh, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400228/
https://www.ncbi.nlm.nih.gov/pubmed/34440516
http://dx.doi.org/10.3390/life11080771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400228/
https://www.ncbi.nlm.nih.gov/pubmed/34440516
http://dx.doi.org/10.3390/life11080771

Ejemplares similares